CY1111733T1 - Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri - Google Patents
Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssriInfo
- Publication number
- CY1111733T1 CY1111733T1 CY20111100495T CY111100495T CY1111733T1 CY 1111733 T1 CY1111733 T1 CY 1111733T1 CY 20111100495 T CY20111100495 T CY 20111100495T CY 111100495 T CY111100495 T CY 111100495T CY 1111733 T1 CY1111733 T1 CY 1111733T1
- Authority
- CY
- Cyprus
- Prior art keywords
- indolysulfanyl
- ssri
- benzylamine
- production
- indolylsulfanyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
Η παρούσα εφεύρεση αναφέρεται σε παράγωγα ανιλίνης του γενικού τύπου I και στη χρησιμοποίησή τους.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53259303P | 2003-12-23 | 2003-12-23 | |
DKPA200301923 | 2003-12-23 | ||
EP07017638A EP1860100B1 (en) | 2003-12-23 | 2004-12-21 | 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1111733T1 true CY1111733T1 (el) | 2015-10-07 |
Family
ID=34712442
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100801T CY1108230T1 (el) | 2003-12-23 | 2008-07-30 | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri |
CY20111100495T CY1111733T1 (el) | 2003-12-23 | 2011-05-20 | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100801T CY1108230T1 (el) | 2003-12-23 | 2008-07-30 | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri |
Country Status (18)
Country | Link |
---|---|
US (4) | US7563908B2 (el) |
EP (1) | EP1701940B1 (el) |
JP (3) | JP4090491B2 (el) |
AT (1) | ATE396970T1 (el) |
AU (1) | AU2004303461B2 (el) |
BR (1) | BRPI0417858B1 (el) |
CY (2) | CY1108230T1 (el) |
DE (1) | DE602004014190D1 (el) |
DK (1) | DK1701940T3 (el) |
ES (1) | ES2303960T3 (el) |
HR (2) | HRP20080274T3 (el) |
IL (1) | IL176111A (el) |
MX (1) | MXPA06007172A (el) |
PL (1) | PL1701940T3 (el) |
PT (1) | PT1701940E (el) |
RS (1) | RS50589B (el) |
SI (1) | SI1701940T1 (el) |
WO (1) | WO2005061455A1 (el) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1701940E (pt) * | 2003-12-23 | 2008-07-30 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-benzil-amina como ssri |
AR052308A1 (es) * | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
AR054394A1 (es) * | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de 2- (1h-indolilsulfanil)-aril amina |
US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
WO2007107165A1 (en) * | 2006-03-22 | 2007-09-27 | H. Lundbeck A/S | Method for identifying compounds for the treatment of depression |
TW200819426A (en) | 2006-08-31 | 2008-05-01 | Lundbeck & Co As H | Novel indane compounds |
CN101563320B (zh) * | 2006-09-28 | 2012-05-30 | H.隆德贝克有限公司 | 用于治疗情感障碍的[2-(6-氟-1h-吲哚-3-基硫烷基)苄基]甲胺 |
EP2074091B1 (en) * | 2006-09-28 | 2015-01-07 | H. Lundbeck A/S | [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
US20100286226A1 (en) * | 2007-09-24 | 2010-11-11 | H. Lundbeck A/S | Combination therapy related to serotonin dual action compounds |
TW200938189A (en) * | 2008-03-13 | 2009-09-16 | Lundbeck & Co As H | [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
JP2011528005A (ja) * | 2008-07-15 | 2011-11-10 | エフ.ホフマン−ラ ロシュ アーゲー | 置換インドリル及びインダゾリル誘導体及びそれらの使用 |
US9000025B2 (en) | 2010-08-20 | 2015-04-07 | Amira Pharmaceuticals, Inc. | Autotaxin inhibitors and uses thereof |
WO2012166415A1 (en) | 2011-05-27 | 2012-12-06 | Amira Pharmaceuticals, Inc. | Heterocyclic autotaxin inhibitors and uses thereof |
EP3046905A4 (en) | 2013-09-17 | 2017-03-22 | Pharmakea Inc. | Vinyl autotaxin inhibitor compounds |
US9951026B2 (en) | 2013-09-17 | 2018-04-24 | Pharmakea, Inc. | Heterocyclic vinyl autotaxin inhibitor compounds |
WO2015048301A1 (en) | 2013-09-26 | 2015-04-02 | Pharmakea, Inc. | Autotaxin inhibitor compounds |
NZ720478A (en) | 2013-11-22 | 2022-02-25 | Sabre Therapeutics Llc | Autotaxin inhibitor compounds |
WO2016191427A1 (en) | 2015-05-27 | 2016-12-01 | Pharmakea, Inc. | Autotaxin inhibitors and uses thereof |
WO2018191146A1 (en) | 2017-04-10 | 2018-10-18 | Navitor Pharmaceuticals, Inc. | Heteroaryl rheb inhibitors and uses thereof |
Family Cites Families (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2003023A (en) * | 1930-10-16 | 1935-05-28 | Westinghouse Electric & Mfg Co | Mercury vapor or noble gas rectifier with arc control |
US3803143A (en) * | 1969-09-08 | 1974-04-09 | Eisai Co Ltd | 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines |
US4018830A (en) * | 1969-09-22 | 1977-04-19 | Merck & Co., Inc. | Phenylthioaralkylamines |
US4055665A (en) * | 1974-11-25 | 1977-10-25 | Merck & Co., Inc. | Treating arrythmia with phenylthioaralkylamines |
US4056632A (en) * | 1975-07-21 | 1977-11-01 | Burroughs Wellcome Co. | 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use |
US4241071A (en) * | 1977-01-27 | 1980-12-23 | American Hoechst Corporation | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes |
US4198417A (en) * | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenoxyphenylpiperidines |
DE3640475A1 (de) | 1986-11-27 | 1988-06-09 | Hoechst Sa Lab | Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung |
EP0396827A1 (en) | 1989-05-09 | 1990-11-14 | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu | 2-Phenylthiobenzylamine dervivatives and acid addition salts thereof |
GB8912971D0 (en) | 1989-06-06 | 1989-07-26 | Wellcome Found | Halogen substituted diphenylsulfides |
US6645969B1 (en) * | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
ES2143992T3 (es) * | 1991-11-25 | 2000-06-01 | Pfizer | Derivados de 5-(hetero- o carbociclilamino)-indol, su preparacion y uso como 5-ht1 agonistas. |
GB9126311D0 (en) | 1991-12-11 | 1992-02-12 | Wellcome Found | Substituted diphenylsulfides |
GB9226532D0 (en) | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
AU2395095A (en) * | 1994-04-29 | 1995-11-29 | G.D. Searle & Co. | Method of using (h+/k+) atpase inhibitors as antiviral agents |
HU226635B1 (en) | 1995-01-23 | 2009-05-28 | Asubio Pharma Co | Piperidine and piperazine derivatives, medicines containing them as active ingredient and their use |
ES2128281T1 (es) | 1995-11-06 | 1999-05-16 | Gist Brocades Bv | Proceso de desesterificacion. |
CZ293595A3 (cs) | 1995-11-09 | 1999-12-15 | Farmak A. S. | Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích |
US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
ATE234281T1 (de) * | 1996-08-27 | 2003-03-15 | Wyeth Corp | 4-aminoethoxy-indolderivate als dopamin d2 agonisten und als 5ht1a liganden |
US5906078A (en) * | 1996-10-09 | 1999-05-25 | Gallagher-Kaiser Corporation | Retaining strip for sheet covered enclosures |
GB9725953D0 (en) | 1997-12-08 | 1998-02-04 | Pfizer Ltd | Compounds useful in therapy |
DE19756036A1 (de) * | 1997-12-17 | 1999-06-24 | Merck Patent Gmbh | Amid- und Harnstoffderivate |
US6333146B1 (en) * | 1999-03-10 | 2001-12-25 | Fuji Photo Film Co., Ltd. | Methine compound and silver halide photographic material containing the same |
SK14022001A3 (sk) | 1999-04-02 | 2002-03-05 | Icos Corporation | Inhibítory väzby LFA-1 na ICAM a ich použitie |
CA2372481A1 (en) | 1999-04-30 | 2000-11-09 | The Trustees Of The University Of Pennsylvania | Spect imaging agents for serotonin transporters |
EP1204645A2 (en) | 1999-08-04 | 2002-05-15 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
US6410736B1 (en) * | 1999-11-29 | 2002-06-25 | Pfizer Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
AU769430B2 (en) * | 1999-10-13 | 2004-01-29 | Pfizer Products Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
EP1246815B1 (en) | 1999-12-30 | 2004-03-17 | H. Lundbeck A/S | Phenylpiperazinyl derivatives |
EP1246816B1 (en) | 1999-12-30 | 2004-03-17 | H. Lundbeck A/S | Substituted phenyl-piperazine derivatives, their preparation and use |
MXPA02006590A (es) | 1999-12-30 | 2002-12-13 | Lundbeck & Co As H | Derivados de 4-fenil-1-piperazinilo, -piperidinilo y -tetrahidropiridilo. |
ATE481967T1 (de) * | 2000-02-29 | 2010-10-15 | Mediquest Therapeutics Inc | Melanozyten-tyrosinasehemmer als aufheller von topischen hauttypen |
KR20020097484A (ko) * | 2000-05-19 | 2002-12-31 | 다케다 야쿠힌 고교 가부시키가이샤 | β-씨크리타아제 억제제 |
US6455738B1 (en) * | 2000-07-13 | 2002-09-24 | Rhodia Chimie | Process for the sulfonation of an aromatic compound |
US20030187023A1 (en) * | 2000-07-17 | 2003-10-02 | Keiji Kubo | Sulfone derivatives, process for their production and use thereof |
WO2002015910A1 (en) * | 2000-08-18 | 2002-02-28 | Sterix Limited | 2-substituted estradiol derivative for inhibiting superoxid dismutase |
BR0113445A (pt) * | 2000-09-01 | 2005-04-12 | Fmc Corp | Composto, composição, e, método para o controle de insetos |
AU2001288623A1 (en) * | 2000-09-05 | 2002-03-22 | Tularik, Inc. | Fxr modulators |
EP1193268A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
ATE365753T1 (de) * | 2000-10-06 | 2007-07-15 | Biocompatibles Uk Ltd | Zwitterionische polymere |
AU2002213467A1 (en) * | 2000-10-11 | 2002-04-22 | Chemocentryx, Inc. | Modulation of ccr4 function |
MXPA03004166A (es) | 2000-11-14 | 2003-09-22 | Merck Patent Gmbh | Nuevos usos de combinaciones de agonistas de 5-ht1a e inhibidores de la recaptacion de serotonina. |
US6436938B1 (en) * | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
WO2002062766A2 (en) | 2001-02-07 | 2002-08-15 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
CA2449874C (en) | 2001-06-07 | 2009-06-23 | F. Hoffmann-La Roche Ag | New indole derivatives with 5-ht6 receptor affinity |
US7199147B2 (en) * | 2001-06-12 | 2007-04-03 | Dainippon Sumitomo Pharma Co., Ltd. | Rho kinase inhibitors |
UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
US7064139B2 (en) * | 2001-10-29 | 2006-06-20 | Uniroyal Chemical Company, Inc. | Method for treating retroviral infections |
JP2005509032A (ja) * | 2001-11-14 | 2005-04-07 | シェーリング コーポレイション | カンナビノイドレセプターリガンド |
NZ533217A (en) | 2001-12-21 | 2006-02-24 | Lundbeck & Co As H | Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
ATE371680T1 (de) * | 2002-01-16 | 2007-09-15 | Biocompatibles Uk Ltd | Polymerkonjugate |
US20050261298A1 (en) * | 2002-01-18 | 2005-11-24 | David Solow-Cordero | Methods of treating conditions associated with an Edg-7 receptor |
US20040058284A1 (en) * | 2002-03-01 | 2004-03-25 | Fuji Photo Film Co., Ltd. | Silver halide color photographic light-sensitive material |
RU2314314C2 (ru) * | 2002-03-04 | 2008-01-10 | Джапан Сайенс Энд Текнолоджи Эйдженси | Новые фосфонамиды, способ их получения и их применение |
EP2902464B1 (en) * | 2002-03-29 | 2019-09-18 | Massachusetts Institute Of Technology | Light emitting device including semiconductor nanocrystals |
DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
PE20040574A1 (es) * | 2002-06-19 | 2004-09-08 | Schering Corp | Agonistas de los receptores cannabinoides |
TW200401641A (en) * | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
AU2003267063B2 (en) * | 2002-09-17 | 2009-08-06 | F. Hoffman-La Roche Ag | 2,4-substituted indoles and their use as 5-HT6 modulators |
JP4327091B2 (ja) * | 2002-09-17 | 2009-09-09 | エフ.ホフマン−ラ ロシュ アーゲー | 2,7−置換インドール及び5−ht6モジュレーターとしてのその使用 |
EP1402888A1 (en) * | 2002-09-18 | 2004-03-31 | Jerini AG | The use of substituted carbocyclic compounds as rotamases inhibitors |
US20040266732A1 (en) * | 2002-09-20 | 2004-12-30 | Jorge Galvez | Therapeutic agents, methods, and treatments |
AU2003275259A1 (en) * | 2002-09-26 | 2004-04-19 | Northwestern University | Anti-angiogenic fragments of pigment epithelium-derived factor (pedf) |
US20040137389A1 (en) * | 2002-12-19 | 2004-07-15 | Kouta Fukui | Heat-developable light-sensitive material |
CN100406007C (zh) * | 2002-12-20 | 2008-07-30 | 安姆根有限公司 | 哮喘和过敏性炎症调节剂 |
US7189501B2 (en) * | 2002-12-27 | 2007-03-13 | Fuji Photo Film Co., Ltd. | Silver halide color photographic photosensitive material |
DE10300098A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Ag | Kupfer-Carben-Komplexe und ihre Verwendung |
EP1590388A2 (en) * | 2003-02-05 | 2005-11-02 | Biocompatibles UK Limited | Block copolymers |
TW200505902A (en) * | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
ES2423800T3 (es) * | 2003-03-28 | 2013-09-24 | Novartis Vaccines And Diagnostics, Inc. | Uso de compuestos orgánicos para la inmunopotenciación |
US7244763B2 (en) * | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
WO2005035516A1 (ja) * | 2003-10-10 | 2005-04-21 | Ono Pharmaceutical Co., Ltd. | 新規縮合複素環化合物およびその用途 |
US7229751B2 (en) * | 2003-11-20 | 2007-06-12 | Konica Minolta Medical & Graphic, Inc. | Silver salt photothermographic dry imaging material and image forming method using the same |
MXPA06007054A (es) * | 2003-12-19 | 2007-04-17 | Elixir Pharmaceuticals Inc | Metodos para tratar una enfermedad. |
PT1701940E (pt) * | 2003-12-23 | 2008-07-30 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-benzil-amina como ssri |
SE528250C2 (sv) | 2004-02-27 | 2006-10-03 | Calignum Technologies Ab | Komposition innefattande en initiator och ett förfarande för att behandla trä med kompositionen |
JP4569142B2 (ja) * | 2004-03-22 | 2010-10-27 | コニカミノルタホールディングス株式会社 | 表示素子 |
JP4448730B2 (ja) * | 2004-04-20 | 2010-04-14 | 富士フイルム株式会社 | 感光性組成物、該感光性組成物に用いられる化合物及び該感光性組成物を用いたパターン形成方法 |
WO2006006172A2 (en) | 2004-07-15 | 2006-01-19 | Ramot At Tel Aviv University Ltd. | Use of anti-amyloid agents for treating and typing pathogen infections |
US7732479B2 (en) | 2004-08-19 | 2010-06-08 | Tel Aviv University Future Technology Development L.P. | Compositions for treating amyloid associated diseases |
WO2006022405A1 (ja) | 2004-08-24 | 2006-03-02 | Fujifilm Corporation | ハロゲン化銀カラー写真感光材料及び画像形成方法 |
EP1806337A4 (en) | 2004-10-08 | 2009-11-25 | Banyu Pharma Co Ltd | METHOD FOR THE SYNTHESIS OF A THIOETHER COMPOUND |
EP1833894A1 (en) | 2004-12-16 | 2007-09-19 | Pirelli & C. S.p.A. | Process for manufacturing a thermoplastic elastomeric material |
-
2004
- 2004-12-21 PT PT04803045T patent/PT1701940E/pt unknown
- 2004-12-21 AU AU2004303461A patent/AU2004303461B2/en not_active Ceased
- 2004-12-21 JP JP2006545921A patent/JP4090491B2/ja not_active Expired - Fee Related
- 2004-12-21 BR BRPI0417858-0A patent/BRPI0417858B1/pt not_active IP Right Cessation
- 2004-12-21 MX MXPA06007172A patent/MXPA06007172A/es active IP Right Grant
- 2004-12-21 RS RSP-2008/0315A patent/RS50589B/sr unknown
- 2004-12-21 WO PCT/DK2004/000894 patent/WO2005061455A1/en active Application Filing
- 2004-12-21 DE DE602004014190T patent/DE602004014190D1/de active Active
- 2004-12-21 AT AT04803045T patent/ATE396970T1/de active
- 2004-12-21 PL PL04803045T patent/PL1701940T3/pl unknown
- 2004-12-21 ES ES04803045T patent/ES2303960T3/es active Active
- 2004-12-21 EP EP04803045A patent/EP1701940B1/en active Active
- 2004-12-21 DK DK04803045T patent/DK1701940T3/da active
- 2004-12-21 SI SI200430784T patent/SI1701940T1/sl unknown
-
2005
- 2005-12-21 US US11/314,702 patent/US7563908B2/en not_active Expired - Fee Related
-
2006
- 2006-06-04 IL IL176111A patent/IL176111A/en active IP Right Grant
-
2007
- 2007-06-05 JP JP2007148813A patent/JP4091648B2/ja active Active
- 2007-12-07 JP JP2007316676A patent/JP2008110984A/ja not_active Ceased
-
2008
- 2008-03-07 US US12/044,170 patent/US7652150B2/en not_active Expired - Fee Related
- 2008-03-17 US US12/049,401 patent/US7737170B2/en not_active Expired - Fee Related
- 2008-03-17 US US12/049,403 patent/US7737171B2/en not_active Expired - Fee Related
- 2008-06-19 HR HR20080274T patent/HRP20080274T3/xx unknown
- 2008-07-30 CY CY20081100801T patent/CY1108230T1/el unknown
-
2011
- 2011-05-20 CY CY20111100495T patent/CY1111733T1/el unknown
- 2011-05-27 HR HR20110400T patent/HRP20110400T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111733T1 (el) | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri | |
CY1116754T1 (el) | Παραγωγα νιτροκατεχολης ως αναστολεις της comt | |
SE0303180D0 (sv) | Novel compounds | |
SE0302232D0 (sv) | Novel Compounds | |
EA200601391A1 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
EA200700400A1 (ru) | Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
MA32544B1 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
SE0502254L (sv) | Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
EA200971107A1 (ru) | Катехоламиновые производные, полезные для лечения болезни паркинсона | |
DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
EA201100921A1 (ru) | Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ | |
CY1109569T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
EA200602180A1 (ru) | Производные 2-(1h-индолилсульфанил)ариламина для применения при лечении аффективных расстройств, боли, нгдв и стрессового недержания мочи | |
SE0401465D0 (sv) | New substituted piperdines as modulators of dopamine neurotransmission | |
EA201170344A1 (ru) | Азаиндольные ингибиторы iap | |
DE602007011434D1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate | |
ATE466007T1 (de) | 5-substituierte indol-2-carbonsäureamidderivate | |
UA86873C2 (en) | SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES | |
ATE440836T1 (de) | Verbindungen | |
JO2774B1 (en) | Derivatives (brprazinil bridges) 1-1 new canon and their use as p75 inhibitors | |
DK1904511T3 (da) | Homogemcitabin | |
ATE553088T1 (de) | Substituierte chinolone ii | |
ECSP066555A (es) | Derivados de morfolina como inhibidores de la reabsorcion de norepinefrina |